CD101 topical: Phase II started

Cidara began the open-label, U.S. Phase II RADIANT trial to compare 1% and 3% CD101 gel and 1% and 6% CD101 ointment for up to 3 days vs. standard of care (SOC) oral fluconazole in up to 125 patients....